Unipharma, established in 1990, is a leading pharmaceutical manufacturing company based in Syria. The company operates from a facility that spans approximately 9,666 square meters and adheres to Good Manufacturing Practice (GMP) standards set by the World Health Organization. Unipharma has received GMP approval from the Syrian Ministry of Health and has also secured plant registration and GMP certification from the Russian Federation’s Ministry of Health.
Unipharma produces a wide range of pharmaceutical products, including tablets, syrups, capsules, and ampuled medicines, with a focus on neurological drugs and circulatory stimulants. The company collaborates with international pharmaceutical firms such as HIKMA Pharmaceuticals, JANSSEN, and NOVARTIS to manufacture products under their supervision. Unipharma has a robust distribution network across Syria and exports its products to international markets, aiming to expand its presence in Asia, Africa, and Europe. The company is committed to delivering high-quality, safe, and effective products while maintaining competitive pricing.
Detailed Information
Fields marked — are added by the business owner once they claim this listing.